Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

MON1A Inhibitors

MON1A inhibitors are a class of chemical compounds specifically designed to target and inhibit the function of MON1A, a protein that plays a crucial role in the regulation of vesicle trafficking and endosomal maturation within cells. MON1A, part of the MON1-CCZ1 complex, is responsible for the transition of early endosomes into late endosomes by regulating the recruitment of Rab GTPases, which are key regulators of intracellular membrane transport. This process is essential for the proper sorting and delivery of cargo, including proteins and lipids, to their intended destinations within the cell, particularly to the lysosome for degradation or recycling. Inhibition of MON1A disrupts these trafficking pathways, impairing the endocytic and autophagic pathways, and leading to potential accumulation of undegraded materials in the cell. This makes MON1A inhibitors valuable tools for studying intracellular transport and vesicle maturation.

In research settings, MON1A inhibitors are used to explore the molecular mechanisms underlying endosomal maturation and the broader implications of disrupted vesicle trafficking on cellular homeostasis. By inhibiting MON1A, scientists can investigate how defects in the endosomal-lysosomal pathway affect the sorting and degradation of cellular components, particularly focusing on how the inhibition leads to altered protein and lipid recycling, autophagy, and organelle integrity. This inhibition allows researchers to study the downstream effects on processes such as nutrient sensing, signal transduction, and metabolic regulation, all of which are tightly connected to efficient endosomal maturation and trafficking. Additionally, MON1A inhibitors provide insights into the interactions between MON1A and other proteins involved in vesicle formation, shedding light on the complex networks that coordinate cellular transport systems. Through these studies, the use of MON1A inhibitors enhances our understanding of vesicular trafficking, endosomal maturation, and the broader impact of these processes on cell function and survival.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$31.00
$53.00
$124.00
$374.00
25
(3)

Disrupts the Golgi apparatus by inhibiting protein transport.

Monensin A

17090-79-8sc-362032
sc-362032A
5 mg
25 mg
$155.00
$525.00
(1)

Ionophore that alters endosomal and lysosomal protein processing.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

PI3 kinase inhibitor, affecting vesicle trafficking.

Dynamin Inhibitor I, Dynasore

304448-55-3sc-202592
10 mg
$89.00
44
(2)

Inhibits dynamin, influencing endocytic vesicle formation.

Golgicide A

1005036-73-6sc-215103
sc-215103A
5 mg
25 mg
$191.00
$683.00
11
(1)

Disrupts Golgi-to-ER trafficking.

Nocodazole

31430-18-9sc-3518B
sc-3518
sc-3518C
sc-3518A
5 mg
10 mg
25 mg
50 mg
$59.00
$85.00
$143.00
$247.00
38
(2)

Microtubule-depolymerizing agent, affecting vesicle movement.

Latrunculin A, Latrunculia magnifica

76343-93-6sc-202691
sc-202691B
100 µg
500 µg
$265.00
$815.00
36
(2)

Actin polymerization inhibitor, influencing vesicle trafficking.

Vinblastine

865-21-4sc-491749
sc-491749A
sc-491749B
sc-491749C
sc-491749D
10 mg
50 mg
100 mg
500 mg
1 g
$102.00
$235.00
$459.00
$1749.00
$2958.00
4
(0)

Microtubule-disrupting agent, perturbing vesicle transport.

Pitstop 2

1419320-73-2sc-507418
10 mg
$360.00
(0)

Inhibits clathrin-mediated endocytosis.

SecinH3

853625-60-2sc-203260
5 mg
$278.00
6
(1)

Inhibits cytohesin ARF GEFs, impacting vesicle trafficking.